Home › Funds › Carlyle Group Inc. › OKUR
Carlyle Group Inc. position in OKUR
Onkure Therapeutics Inc · Health Care
Carlyle Group Inc. reported holding 269,895 shares of OKUR (Onkure Therapeutics Inc) in its Q3 2026 13F filing — a position valued at US$735K, representing 0.01% of its reported portfolio and ranking #11 among its reported holdings. Carlyle Group Inc. has disclosed OKUR holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Carlyle Group Inc.'s OKUR position evolved
Carlyle Group Inc. first disclosed a stake in OKUR in Q4 2024 at 269,895 shares (US$2.3M). Across 8 filings, Carlyle Group Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 269,895 shares valued at US$735K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 269.89K | $2.33M | New |
| Q1 2025 | 269.89K | $1.16M | Hold |
| Q2 2025 | 269.89K | $642.35K | Hold |
| Q3 2025 | 269.89K | $742.21K | Hold |
| Q4 2025 | 269.89K | $771.90K | Hold |
| Q1 2026 | 269.89K | $1.12M | Hold |
| Q2 2026 | 269.89K | $1.23M | Hold |
| Q3 2026 | 269.89K | $735.46K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OKUR and 13F data
OKUR (Onkure Therapeutics Inc) is a Health Care company. 72 other funds we track also report a position in OKUR — the largest reported positions include BVF INC/IL (US$14.8M), ACORN CAPITAL ADVISORS, LLC (US$12.9M), StepStone Group LP (US$12.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OKUR
- BVF INC/IL 3.24M sh · $14.76M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 2.84M sh · $12.95M · Q2 2026
- StepStone Group LP 2.66M sh · $12.13M · Q2 2026
- ADAR1 Capital Management, LLC 2.24M sh · $10.21M · Q2 2026
- Trails Edge Capital Partners, LP 1.44M sh · $6.56M · Q2 2026
- Vivo Capital, LLC 1.93M sh · $5.25M · Q3 2026
- Sio Capital Management, LLC 1.08M sh · $4.92M · Q2 2026
- Prosight Management, LP 978.99K sh · $4.46M · Q2 2026
- NEA Management Company, LLC 478.55K sh · $2.18M · Q2 2026
- Sofinnova Investments, Inc. 321.69K sh · $1.47M · Q2 2026
- Rosalind Advisors, Inc. 150.00K sh · $684.00K · Q2 2026
- Aisling Capital Management LP 88.61K sh · $241.45K · Q3 2026
More on Carlyle Group Inc.
FAQ
How long has Carlyle Group Inc. held OKUR?
Carlyle Group Inc. has disclosed OKUR holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Carlyle Group Inc.'s current position in OKUR?
As of Q3 2026, Carlyle Group Inc. holds 269.89K shares of OKUR (Onkure Therapeutics Inc), valued at $735.46K, representing 0.01% of its reported portfolio and ranking #11.
Has Carlyle Group Inc. been buying or selling OKUR?
In the latest 13F filing (Q3 2026), Carlyle Group Inc. held unchanged its position in OKUR.
Which other funds hold OKUR?
Other major institutional holders of OKUR include BVF INC/IL, ACORN CAPITAL ADVISORS, LLC, StepStone Group LP, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.